If you were watching the market yesterday, you may have noticed the complete lunacy on display as shares of Tilray breached $250 per share. It’s almost impossible to fathom such irrational exuberance. When the company CEO sat down on CNBC’s Mad Money recently, talking about his company reaching a $100 billion market cap, people must have […]
Some of our American readers may recall an animated series that was once quite popular in ‘Murica called King of the Hill. One memorable skit from that series was when Hank Hill – best described as a slightly redneck, beer-swilling propane salesman – meets his Asian-looking neighbor and asks him “are you Chinese or Japanese?“, to which […]
It was only last week that we saw a new AI unicorn birthed alongside speculation that this AI unicorn had also confidentially filed for an IPO. This led us to pontificate a bit about how AI is not the next dot-com because this time it’s different. This time, the technology that everyone is raving about […]
We first talked about AI unicorns earlier this year, and now the tech world’s newest AI unicorn is reportedly already looking to make the leap to IPO as early as this year. The news broke last week that Afiniti, which uses artificial intelligence to match call center employees with customers in a sales version of […]
We’ve talked before about how the Internet of Things (IoT) will open up the door for billions of devices to connect to “the cloud” and provide us with even more “big data” sets that we can learn from. While there are all kinds of IoT devices being developed, inexpensive RFID tags (also referred to as “tag […]
2016 hasn’t started out too well for equity investors, with the S&P 500 dropping -6% in the first week of 2016 trading alone. This doesn’t bode well for IPOs, especially for biotech IPOs, which were hot in 2015 but have been punished as of late. One of our most popular articles in the past few months has […]
The U.S. market for branded prescription drugs for acne was estimated to be approximately $2.6 billion for the 12 months ended March 31, 2014, of which $1.6 billion was attributed to topical drugs such as Epiduo and Aczone and $1 billion was attributed to oral drugs. Orally administered Solodyn is the brand name for an antibiotic […]
With grand promises of future growth, the well-hyped 3D printing “sector” has started to see some IPO activity. On February 2013 we saw the IPO of ExOne (NASDAQ:XONE), a company that specializes in the 3D printing of metals. On October 18th, 2013 we saw the IPO of Voxeljet (NYSE:VJET), a company that sells 3D printers, one of which […]
If we are to believe the Nanalyze website data trends, it seems that most of our readers probably have very little knowledge of female contraceptives, other than what their significant others may make mention of occasionally. What should be of interest to any investor regardless of their gender, is that the global contraceptives market is […]
Investors in pure-play 3D printing companies have fared well this year with the 2 biggest players by market cap, Stratasys (NASDAQ:SSYS) and 3D Systems (NYSE:DDD), up +22% and +51% respectively. The first IPO in the 3D printing sector, ExOne (NASDAQ:XONE), has paid investors handsomely since February this year with an +80% return. The second 3D […]